-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

701. Experimental Transplantation: Basic and Translational: Poster II

Symposia: Experimental Transplantation: Basic and Translational Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Ziyi Hu1,2*, Yuxi Xu, MS2,3*, Yuxuan He1,2*, Qing Xu1,2*, Ya Zhou1,2*, Qi Wang1,2*, Xiaodong Xie1,2*, Rui Wang1,2*, Xiaoqi Wang, MD1*, Shijie Yang, PhD1*, Qingxiao Song, MD, PhD1,2 and Xi Zhang, PhD2,4

1Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, China
2Jinfeng Laboratory, Chongqing, China
3Medical Center of Hematology, Xinqiao Hospital of Army Medical University, Chongqing, AL, China
4Medical Center of Hematology, Xinqiao Hospital of Army Medical University, State Key Laboratory of Trauma and Chemical Poisoning, Chongqing Key Laboratory of Hematology and Microenvironment, Chongqing, China

Melissa Zwick1,2*, Bastian Zinkel1,2*, Corinna Spohr3*, Tamina Rückert1*, Sebastian Halbach3,4*, Khalid Shoumariyeh, MD1,4*, Lukas M. Braun1,2*, Annika Nelde5,6*, Melanie Maerklin6,7*, Samuel J. Holzmayer6,7*, Sandra Duquesne1*, Alexandra Emilia Schlaak8*, Patricia Otto-Mora8*, Bertram Bengsch8,9,10,11*, Marcel Schiff1*, Sandra Kissel1*, Marie Follo1*, Heidi Altmann12*, Désirée Kunadt12*, Anna Lena Illert1,4,13,14*, Juliane S. Walz, MD5,6,7,15*, Gerd Walz9,16,17*, Justus Duyster, MD1,18*, Johannes Schetelig, MD, MSc11,12, Tilman Brummer, PhD3,4,9,19*, Robert Zeiser, MD1,4,9,17 and Natalie Koehler1,17*

1Department of Medicine I, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
2Faculty of Biology, University of Freiburg, Freiburg, Germany
3Institute of Molecular Medicine and Cell Research (IMMZ), Zentrum für Biochemie und Molekulare Zellforschung (ZBMZ), Faculty of Medicine, University of Freiburg, Freiburg, Germany
4German Cancer Consortium (DKTK), Partner Site Freiburg and German Cancer Research Center (DKFZ), Heidelberg, Germany
5Department of Peptide-based Immunotherapy, Institute of Immunology, University and University Hospital Tübingen, Tübingen, Germany
6Cluster of Excellence iFIT (EXC2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany
7Clinical Collaboration Unit Translational Immunology, Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany
8Department of Internal Medicine II (Gastroenterology, Hepatology, Endocrinology and Infectious Diseases), Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
9BIOSS Center for Biological Signalling Studies, University of Freiburg, Freiburg, Germany
10German Cancer Consortium (DKTK), Heidelberg, Germany
11Clinical Trials Unit, DKMS gGmbH, Dresden, Germany
12Department of Internal Medicine I, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany
13Department of Medicine III, Klinikum Rechts der Isar, Faculty of Medicine, Technical University of Munich, Munich, Germany
14TranslaTUM, Center for Translational Cancer Research, Technical University of Munich, Munich, Germany
15German Cancer Consortium (DKTK), Partner Site Tübingen and German Cancer Research Center (DKFZ), Tübingen, Germany
16Renal Division, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany
17CIBSS – Centre for Integrative Biological Signalling Studies, University of Freiburg, Freiburg, Germany
18German Cancer Consortium (DKTK), Partner site Freiburg; and German Cancer Research Center (DKFZ), Heidelberg, Germany
19Comprehensive Cancer Center Freiburg (CCCF), Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany

Ji Eun Lim, PhD1*, Srideshikan Sargur Madabushi, PhD1, Mengistu Lemecha Shukare, PhD2*, Hemendra Ghimire, PhD1*, Jenny Paredes, PhD3, Sally Mokhtari, PhD4, James F. Sanchez, PhD4*, Karamjeet S Sandhu, MD3, Amandeep Salhotra, MD3, Ryotaro Nakamura, MD3, Jeffrey Wong, MD1*, Anthony S. Stein, MD3, Dorothy Schaue5*, Marcel R.M. van den Brink, MD, PhD3, Monzr M. Al Malki, MD3, Guy Storme, MD, PhD6* and Susanta Hui, PhD1*

1Radiation Oncology, City of Hope National Medical Center, Duarte, CA
2Department of Molecular and Cellular Biology, City of Hope National Medical Center, Duarte, CA
3Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
4Clinical and Translational Project Development, City of Hope National Medical Center, Duarte, CA
5Department of Radiation Oncology, University of California, Los Angeles (UCLA), Los Angeles, CA
6Department of Radiotherapy Universitair Ziekenhuis (UZ) Brussels, Brussels, Belgium

Shanid Mohiyuddin, PhD1*, Vasantharaja Raguraman, PhD1*, Nashwan Jabbour, MD2*, Melissa Kesler, MD2*, Jayakrishna Ambati3*, Senthilnathan Palaniyandi, PhD1* and Gerhard C Hildebrandt, MD1

1Department of Medicine, Ellis Fischel Cancer Center, University of Missouri, Columbia, MO
2University of Kentucky, Lexington, KY
3University of Virginia School of Medicine, Charlottesville, VA

Jose Antonio Bejarano Garcia*, Melanie Nufer*, Maria Jose Palacios Barea*, Beatriz Guijarro-Albaladejo*, Inmaculada Carrasco Brocal*, Belén Sierro*, Estefania Garcia-Guerrero, PhD*, Maribel Lara Chica*, Teresa Caballero, PhD, MD*, Alfonso Rodríguez-Gil, PhD* and Jose Antonio Pérez-Simón, MD, PhD

Instituto de Biomedicina de Sevilla (Consejo Superior de Investigaciones Científicas (CSIC), Universidad de Sevilla (US), Hospital Universitario Virgen del Rocío (HUVR))., Sevilla, Spain

Qianqian Huang, PhD1*, Xinya Jiang2*, Bixia Wang3*, Zhigui Wu1*, Fangqing Zhang1*, Huidong Guo4* and Xiao Jun Huang, MD5

1Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China
2Xiangya Hospital, Central South University, Changsha, China
3Peking University People’s Hospital, Beijing, China
4*Correspondence should be addressed to Xiao-Jun Huang or Huidong Guo, Peking University People's Hospital & Peking University Institute of Hematology, Beijing, China
5Peking University People’s Hospital, Peking University Institute of Hematology, Beijing, China

Juan Vargas1,2*, Isabell Lang3*, Svetlana Stepanzow3*, Olena Zaitseva3*, Estibaliz Arellano-Viera4*, Carolin Graf4*, Haroon Shaikh, PhD2*, Muhammad Daud5*, Sophie Barkey5*, Harald Wajant6* and Andreas Beilhack7*

1University Clinic Würzburg, Würzburg, Germany
2Department of Medicine II, University Hospital Würzburg, Würzburg, Germany
3Division of Molecular Internal Medicine, Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany
4Würzburg University Clinics, Würzburg, Germany
5Interdisciplinary Center for Clinical Research (IZKF) Experimental Stem Cell Transplantation Laboratory, Würzburg University Hospital, Würzburg, Germany
6University Hospital Würzburg, Würzburg, DEU
7Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany

Wentao Han1, Hassan Bjeije2*, Hamza Celik, PhD3*, Michael P. Rettig, PhD2, Yanan Li, PhD4*, Andrew L Young, MD, PhD5, Christine RC Zhang, PhD2, Infencia Xavier Raj, BS, MS6, Saranajith Dunuwille, PhD2* and Grant A Challen, PhD2

1Division of Oncology, Washington University School of Medicine, Saint Louis, MO
2Division of Oncology, Washington University School of Medicine, St. Louis, MO
3Incyte Research Institute, Wilmington, DE
4Department of Pediatrics, Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO
5Division of Hematology, Washington University School of Medicine in St. Louis, St. Louis, MO
6Division of Oncology, Washington University In St. Louis, Saint Louis, MO

Verena Holzmüller1,2,3*, Ulrich Thienel, MD, PhD4*, Jana Gawron1,3*, Kenji Cunnion, MD5*, Neel Krishna, PhD5*, Lindsey Glenn5* and Robert Zeiser, MD2,6

1Department of Medicine I, University Medical Center Freiburg, Freiburg, Germany
2Spemann Graduate School of Biology and Medicine (SGBM), University of Freiburg, Freiburg, Germany
3Faculty of Biology, University of Freiburg, Freiburg, Germany
4UT Partners, New York, NY
5ReAlta Life Sciences, Norfolk, VA
6University of Freiburg, Faculty of Medicine, Albert Ludwigs University (ALU), Freiburg, Germany, Freiburg, Germany, Freiburg, Germany

Xiaolin Yuan, MD1,2,3*, Lingbo Yi4*, Yibo Wu, MD1,3,5*, Yishan Ye, MD1*, Luxin Yang, MD6*, Panpan Zhu1*, Zhiyang Yuan, PhD4*, He Huang, MD1,3,7*, Shanshan Pei, PhD1,3,5* and Yi Luo5,8,9

1Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, hangzhou, China
2Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, hangzhou, China
4Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China
5Institute of Hematology, Zhejiang University, hangzhou, China
6Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
7Institute of Hematology, Zhejiang University, Hangzhou, China
8Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, hangzhou, China
9Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China

Wei-Hsin Liu, MD1, Aloukick Singh, PhD2*, Sandeep Yadav, PhD2*, Esther Bachar Lustig, PhD1* and Yair Reisner, PhD1,3,4

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Immunology & Regenerative Biology, Weizmann institute of science, Rehovot, Israel
4CPRIT Scholar in Cancer Research, Houston, TX

Haroon Shaikh, PhD1*, Ivana Jorgacevic, PhD2*, Hla Ali, MSc2*, Maja Bundalo, PhD2*, Sarah Schäfer, PhD2*, Michael AG Kern1*, Maike Büttner- Herold, MD3*, Clément Cochain, PhD2*, Antoine-Emmanuel Saliba, PhD4*, Giuseppe Rizzo, PhD2*, Juan Vargas1*, Louis Boon, PhD5*, Wolfgang Herr, MD6, Hermann Einsele, MD1*, Friederike Berberich-Siebelt, MD7*, Andreas Rosenwald, MD8*, Andreas Beilhack9* and Alma Zernecke, MD2*

1Department of Medicine II, University Hospital Würzburg, Würzburg, Germany
2Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany
3Department of Nephropathology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany
4Helmholtz Institute for RNA-based Infection Research (HIRI), Würzburg, Germany
5JJP Biologics, Warsaw, Poland
6Internal Medicine III - Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
7Institute of Pathology, Julius-Maximilians-Universität Würzburg, Würzburg, Germany
8Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany
9Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany

Ying WANG1*, Alicia Huaze Li2*, Ruqayyah sanders-Braggs3*, Yan Zhou, MS4*, Mimi Chen, PhD5*, Tien Bui3*, Hongfa Zhu6*, Nasheed Hossain, MD7*, Jonathan Soboloff8*, John Elrod9*, Elizabeth O. Hexner, MD, MSTR10 and Yi Zhang, MD, PhD5

1Center for Discovery and Innovation, Hackensack Meridian Health, Nutley, NJ
2Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia
3Center for Discovery and Innovation, Hackensack University Medical Center, Nutley
4Fox Chase Cancer Center, Temple University, Philadelphia
5Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ
6Hackensack Meridian Health, Hackensack
7Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
8Temple University School of Medicine, Philadelphia, PA
9Center for Translational Medicine, Temple University, Philadelphia
10Abramson Cancer Center, Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA

Xie-Na Cao, MD, PhD1*, Wen-Kai Zhang, MD1*, Wei Shi, PhD2*, Ling-Hui Xia, MD, PhD1*, Li Li, MD3*, Chun-Yan Sun, MD1* and Yu Hu4*

1Institute of Haematology, Huazhong University of Science and Technology, Union Hospital, Tongji Medical School, Wuhan, China
2Institute of Hematology, Union Hospital, Tongji Medical School, Huazhong University of Science and Technology, Wuhan, China
3Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD
4Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China

*signifies non-member of ASH